bpc 157 systemic effects Stable Gastric Pentadecapeptide 157—Possible Novel Therapy of Glaucoma and Other Ocular Conditions BPC-157: What Research Shows (and

These arent empty promises

Cohen deemed MOTS -c promising enough that he founded a company to take it into a Phase I clinical trialan early step on the road toward F.D.A

Their scalable nature and compatibility with advanced analytical techniques make peptides valuable across both foundational studies and ongoing research development, supporting consistent, reproducible outcomes in controlled scientific environments

But we cant find a receptor, cant name a target, and cant find a gene for it in your genome is just giving up on science entirely

doi: 10.1016/B978-0-12-811907-5.00005-1

Continuously injecting into the same spot can lead to lipohypertrophy, a buildup of fatty tissue that can hinder absorption, or lipoatrophy, a loss of fat that can cause dents in the skin